Glaukos Quarterly Cash Flow Statement
NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Glaukos free cash flow
In the quarter ended Jun 30, 2026, Glaukos generated $14.8 million of operating cash flow and spent $2.7 million on capital expenditures. That left free cash flow of $12.1 million, a free-cash-flow margin of 6.5% of revenue. Free cash flow was up 108.4% from the prior year's $5.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
Glaukos cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -18.38M | -19.78M | -133.66M | -16.23M | -19.66M | -18.15M | -33.58M | -21.41M | -50.55M | -40.84M | -36.78M | -30.44M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 8.87M | 11.80M | 12.16M | 9.13M | 8.57M | 8.23M | 8.74M | 9.00M | 9.00M | 8.91M | 2.29M | 2.23M |
| Stock-Based Compensation | 28.86M | 19.14M | 17.30M | 14.91M | 18.02M | 12.99M | 13.31M | 14.42M | 11.31M | 11.16M | 12.99M | 10.48M |
| Change in Working Capital | -5.51M | -21.82M | -3.07M | -10.33M | -7.78M | -20.71M | -2.26M | -6.99M | -12.56M | -19.49M | 4.86M | 2.32M |
| Operating Cash Flow | 14.82M | -12.53M | 6.84M | -10.09M | 6.98M | -18.52M | 507.00K | -9.59M | -18.37M | -33.87M | -10.66M | -8.17M |
| Capital Expenditures | -2.74M | -3.96M | -2.91M | -1.64M | -1.18M | -1.94M | -1.73M | -1.45M | -2.15M | -968.00K | -4.21M | -3.36M |
| Investing Cash Flow | -5.31M | 10.50M | -15.89M | -3.99M | -20.78M | -36.95M | 11.79M | 30.56M | 34.86M | -29.38M | -12.92M | 14.90M |
| Financing Cash Flow | 991.00K | 15.77M | 2.43M | 5.26M | 2.25M | 1.95M | 60.11M | 9.67M | 8.59M | 13.17M | 7.30M | 7.47M |
| Net Change in Cash | 9.52M | 13.44M | -7.43M | -2.57M | -14.34M | -55.37M | 69.48M | 32.07M | 24.46M | -50.97M | -15.46M | 14.12M |
| Free Cash Flow | 12.09M | -16.48M | 3.93M | -11.72M | 5.80M | -20.46M | -1.23M | -11.04M | -20.52M | -34.84M | -14.88M | -11.53M |
This table shows 12 quarterly periods of Glaukos's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GKOS's reporting calendar. What is a cash flow statement?